Advances in asthma 2015: Across the lifespan.

[1]  J. Nadel,et al.  Understanding the pathophysiology of the asthma–chronic obstructive pulmonary disease overlap syndrome , 2016, Current opinion in pulmonary medicine.

[2]  P. Gergen,et al.  Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. , 2015, The Journal of allergy and clinical immunology.

[3]  M. Loane,et al.  Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study. , 2015, The Journal of allergy and clinical immunology.

[4]  S. Park,et al.  Effect of pregnancy in asthma on health care use and perinatal outcomes. , 2015, The Journal of allergy and clinical immunology.

[5]  N. Flamand,et al.  Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma. , 2015, The Journal of allergy and clinical immunology.

[6]  Joseph R Arron,et al.  The airway microbiome in patients with severe asthma: Associations with disease features and severity. , 2015, The Journal of allergy and clinical immunology.

[7]  S. Szefler,et al.  New and future strategies to improve asthma control in children. , 2015, The Journal of allergy and clinical immunology.

[8]  A. Liu.  Revisiting the hygiene hypothesis for allergy and asthma. , 2015, The Journal of allergy and clinical immunology.

[9]  T. Omachi,et al.  Asthma exacerbations and lung function in patients with severe or difficult-to-treat asthma. , 2015, The Journal of allergy and clinical immunology.

[10]  A. Heinzmann,et al.  Polymorphisms related to ORMDL3 are associated with asthma susceptibility, alterations in transcriptional regulation of ORMDL3, and changes in TH2 cytokine levels. , 2015, The Journal of allergy and clinical immunology.

[11]  Tobias Kollmann,et al.  Early infancy microbial and metabolic alterations affect risk of childhood asthma , 2015, Science Translational Medicine.

[12]  R. Van Ree,et al.  International consensus on allergy immunotherapy. , 2015, The Journal of allergy and clinical immunology.

[13]  H. Reddel.  Treatment of overlapping asthma-chronic obstructive pulmonary disease: Can guidelines contribute in an evidence-free zone? , 2015, The Journal of allergy and clinical immunology.

[14]  D. Postma,et al.  Revisiting the Dutch hypothesis. , 2015, The Journal of allergy and clinical immunology.

[15]  N. Krug,et al.  Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma. , 2015, The Journal of allergy and clinical immunology.

[16]  M. Tingen,et al.  Comparison of asthma prevalence among African American teenage youth attending public high schools in rural Georgia and urban Detroit. , 2015, The Journal of allergy and clinical immunology.

[17]  E. Israel,et al.  Impact of Age and Sex on Response to Asthma Therapy. , 2015, American journal of respiratory and critical care medicine.

[18]  Jordan A. Ramilowski,et al.  Transcriptome analysis of controlled and therapy-resistant childhood asthma reveals distinct gene expression profiles. , 2015, The Journal of allergy and clinical immunology.

[19]  P. Barnes.  Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. , 2015, The Journal of allergy and clinical immunology.

[20]  L. Bacharier,et al.  Reply: To PMID 25458910. , 2015, The Journal of allergy and clinical immunology.

[21]  S. Johnston,et al.  The influence of asthma control on the severity of virus-induced asthma exacerbations. , 2015, The Journal of allergy and clinical immunology.

[22]  A. Bush,et al.  Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33 , 2015, The Journal of allergy and clinical immunology.

[23]  H. Renz,et al.  Childhood allergic asthma is associated with increased IL-13 and FOXP3 histone acetylation. , 2015, The Journal of allergy and clinical immunology.

[24]  P. Holt.  The mechanism or mechanisms driving atopic asthma initiation: The infant respiratory microbiome moves to center stage. , 2015, The Journal of allergy and clinical immunology.

[25]  A. Magnan,et al.  Prevention of allergic asthma through Der p 2 peptide vaccination. , 2015, The Journal of allergy and clinical immunology.

[26]  Brent S. Pedersen,et al.  DNA methylation and childhood asthma in the inner city. , 2015, The Journal of allergy and clinical immunology.

[27]  C. Mills,et al.  Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years , 2015, The Journal of allergy and clinical immunology.

[28]  Jonathan D. Campbell,et al.  Measuring the effect of asthma control on exacerbations and health resource use. , 2015, Journal of Allergy and Clinical Immunology.

[29]  Randall Brown,et al.  Asthma outcomes in children and adolescents with multiple morbidities: Findings from the National Health Interview Survey. , 2015, The Journal of allergy and clinical immunology.

[30]  Christine Jenkins,et al.  Development and validation of a novel risk score for asthma exacerbations: The risk score for exacerbations. , 2015, The Journal of allergy and clinical immunology.

[31]  Jeremy Wildfire,et al.  Seasonal risk factors for asthma exacerbations among inner-city children. , 2015, The Journal of allergy and clinical immunology.

[32]  A. Fitzpatrick,et al.  Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma. , 2015, The Journal of allergy and clinical immunology.

[33]  C. Bachert,et al.  Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme. , 2015, The New England journal of medicine.

[34]  K. Chung,et al.  Increased phenotypic differentiation and reduced corticosteroid sensitivity of fibrocytes in severe asthma. , 2015, The Journal of allergy and clinical immunology.

[35]  E. Bateman,et al.  Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. , 2015, The Lancet. Respiratory medicine.

[36]  J. Baty,et al.  Randomized trial to evaluate azithromycin's effects on serum and upper airway IL-8 levels and recurrent wheezing in infants with respiratory syncytial virus bronchiolitis. , 2015, The Journal of allergy and clinical immunology.

[37]  Cheng-Hsien Liu,et al.  Fibrocyte trafficking in patients with chronic obstructive asthma and during an acute asthma exacerbation. , 2015, The Journal of allergy and clinical immunology.

[38]  J. Swann,et al.  The effect of geographic access on severe health outcomes for pediatric asthma. , 2015, The Journal of allergy and clinical immunology.

[39]  Daniel J. Jackson,et al.  Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication , 2015, Proceedings of the National Academy of Sciences.

[40]  A. Zwinderman,et al.  The prevalence of severe refractory asthma. , 2015, The Journal of allergy and clinical immunology.

[41]  U. Frey,et al.  Dynamics of the nasal microbiota in infancy: a prospective cohort study. , 2015, The Journal of allergy and clinical immunology.

[42]  A. Klion,et al.  Biologic therapies targeting eosinophils: current status and future prospects. , 2015, The journal of allergy and clinical immunology. In practice.

[43]  S. Szefler,et al.  Advances in pediatric asthma in 2014: Moving toward a population health perspective. , 2015, The Journal of allergy and clinical immunology.

[44]  Meghan F. Davis,et al.  Staphylococcus aureus colonization is associated with wheeze and asthma among US children and young adults. , 2015, The Journal of allergy and clinical immunology.

[45]  R. Peng,et al.  Neighborhood poverty, urban residence, race/ethnicity, and asthma: Rethinking the inner-city asthma epidemic. , 2015, The Journal of allergy and clinical immunology.

[46]  W. Busse,et al.  Biologics in asthma--the next step toward personalized treatment. , 2015, The journal of allergy and clinical immunology. In practice.

[47]  M. Cabana,et al.  The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy. , 2015, The Journal of allergy and clinical immunology.

[48]  M. Hernandez,et al.  IL-1 receptor antagonist reduces endotoxin-induced airway inflammation in healthy volunteers. , 2015, The Journal of allergy and clinical immunology.

[49]  M. Casas,et al.  Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy. , 2015, The Journal of allergy and clinical immunology.

[50]  A. Litonjua,et al.  Prenatal and infant exposure to acetaminophen and ibuprofen and the risk for wheeze and asthma in children. , 2015, The Journal of allergy and clinical immunology.

[51]  I. Pavord,et al.  Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease , 2015, The Journal of allergy and clinical immunology.

[52]  B. Toelle,et al.  Rhinoviruses significantly affect day-to-day respiratory symptoms of children with asthma , 2014, Journal of Allergy and Clinical Immunology.

[53]  J. Kere,et al.  Risk of childhood asthma is associated with CpG-site polymorphisms, regional DNA methylation and mRNA levels at the GSDMB/ORMDL3 locus , 2014, Human molecular genetics.

[54]  H. Ortega,et al.  Cluster analysis and characterization of response to mepolizumab. A step closer to personalized medicine for patients with severe asthma. , 2014, Annals of the American Thoracic Society.

[55]  I. Pavord,et al.  Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. , 2014, The New England journal of medicine.

[56]  O. Ruuskanen,et al.  Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode , 2014, Journal of Allergy and Clinical Immunology.

[57]  R. Crameri,et al.  Fungi: the neglected allergenic sources , 2014, Allergy.

[58]  Thomas Blicher,et al.  A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations , 2013, Nature Genetics.

[59]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[60]  T. Mahr,et al.  Rhinovirus Wheezing Illness and Genetic Risk of Childhood-Onset Asthma , 2013, Pediatrics.

[61]  Hans Bisgaard,et al.  Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. , 2013, The New England journal of medicine.

[62]  M. Jaakkola,et al.  Residential Dampness and Molds and the Risk of Developing Asthma: A Systematic Review and Meta-Analysis , 2012, PloS one.

[63]  Mark J. Mendell,et al.  Respiratory and Allergic Health Effects of Dampness, Mold, and Dampness-Related Agents: A Review of the Epidemiologic Evidence , 2011, Environmental health perspectives.

[64]  Wai-ming Lee,et al.  Association between human rhinovirus C and severity of acute asthma in children , 2010, European Respiratory Journal.

[65]  W. Fisk,et al.  Meta-analyses of the associations of respiratory health effects with dampness and mold in homes. , 2007, Indoor air.

[66]  S. Szefler,et al.  Advances in pediatric asthma 2006. , 2007, The Journal of allergy and clinical immunology.

[67]  H. Boushey,et al.  Chapter 15 – The Microbiome in Asthma: Potential Impact on Phenotype and Medication Response , 2018 .

[68]  M. Beauchesne,et al.  Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. , 2015, The Journal of allergy and clinical immunology.

[69]  N. Bearman,et al.  Indoor fungal diversity and asthma: a meta-analysis and systematic review of risk factors. , 2015, The Journal of allergy and clinical immunology.

[70]  T. Illig,et al.  Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. , 2015, The Journal of allergy and clinical immunology.

[71]  H. Bisgaard,et al.  The relationship between gut microbiota and inflammatory non-communicable diseases and the potential role for gut microbiota as therapy , 2015 .

[72]  E. Bleecker,et al.  Phenotypic and genotypic association of epithelial IL1RL1 to human TH2-like asthma. , 2015, The Journal of allergy and clinical immunology.

[73]  A. Apter.  Advances in adult asthma diagnosis and treatment in 2014. , 2015, The Journal of allergy and clinical immunology.

[74]  A. Apter.  Advances in adult asthma diagnosis and treatment in 2012: potential therapeutics and gene-environment interactions. , 2013, The Journal of allergy and clinical immunology.